miRNA in clinical practice: Pancreatic cancer

被引：31

作者：

Humeau, Marine ^{[1
,2
,3
]}

Torrisani, Jerome ^{[1
,2
]}

Cordelier, Pierre ^{[1
,2
]}

机构：

[1] INSERM, Ctr Rech Cancerol Toulouse, UMR1037, F-31432 Toulouse 04, France

[2] Univ Toulouse 3, F-31062 Toulouse, France

[3] CHU Toulouse, Serv Chirurg Digest, Toulouse, France

来源：

CLINICAL BIOCHEMISTRY | 2013年 / 46卷 / 10-11期

关键词：

miRNA; Biomarkers; Pancreatic cancer; MICRORNA; EXPRESSION; ADENOCARCINOMA; DIAGNOSIS; CELLS; SERUM; PROLIFERATION; SIGNATURE; BIOMARKER; PATTERNS;

D O I：

10.1016/j.clinbiochem.2013.03.019

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

To date, pancreatic cancer (PDAC) can't be diagnosed early. Consequently, a majority of patient (80%) display an advanced disease that results in a low resection rate leading to an overall median survival of 4 to 6 months. Accordingly, robust markers for the early diagnosis and prognosis of pancreatic cancer, or markers indicative of survival and/or metastatic disease are desperately needed to help alleviate the dismal prognosis of this disease. In this chapter, we review the translational studies demonstrating that miRNAs, alone or in combination, may soon translate into clinical applications as long-awaited screening tools for PDAC. (C) 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

引用

页码：933 / 936

页数：4

共 43 条

[1] Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue [J].

Bauer, Andrea S. ;

Keller, Andreas ;

Costello, Eithne ;

Greenhalf, William ;

Bier, Melanie ;

Borries, Anne ;

Beier, Markus ;

Neoptolemos, John ;

Buechler, Markus ;

Werner, Jens ;

Giese, Nathalia ;

Hoheisel, Joerg D. .

PLOS ONE, 2012, 7 (04)

[2] MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis [J].

Bloomston, Mark ;

Frankel, Wendy L. ;

Petrocca, Fabio ;

Volinia, Stefano ;

Alder, Hansjuerg ;

Hagan, John P. ;

Liu, Chang-Gong ;

Bhatt, Darshna ;

Taccioli, Cristian ;

Croce, Carlo M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (17) :1901-1908

[3] The patterns and dynamics of genomic instability in metastatic pancreatic cancer [J].

Campbell, Peter J. ;

Yachida, Shinichi ;

Mudie, Laura J. ;

Stephens, Philip J. ;

Pleasance, Erin D. ;

Stebbings, Lucy A. ;

Morsberger, Laura A. ;

Latimer, Calli ;

McLaren, Stuart ;

Lin, Meng-Lay ;

McBride, David J. ;

Varela, Ignacio ;

Nik-Zainal, Serena A. ;

Leroy, Catherine ;

Jia, Mingming ;

Menzies, Andrew ;

Butler, Adam P. ;

Teague, Jon W. ;

Griffin, Constance A. ;

Burton, John ;

Swerdlow, Harold ;

Quail, Michael A. ;

Stratton, Michael R. ;

Iacobuzio-Donahue, Christine ;

Futreal, P. Andrew .

NATURE, 2010, 467 (7319) :1109-1113

[4] New biomarkers and targets in pancreatic cancer and their application to treatment [J].

Costello, Eithne ;

Greenhalf, William ;

Neoptolemos, John P. .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (08) :435-444

[5] MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival [J].

Dillhoff, Mary ;

Liu, James ;

Frankel, Wendy ;

Croce, Carlo ;

Bloomston, Mark .

JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (12) :2171-2176

[6] MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions [J].

du Rieu, Mael Chalret ;

Torrisani, Jerome ;

Selves, Janick ;

Al Saati, Talal ;

Souque, Anny ;

Dufresne, Marlene ;

Tsongalis, Gregory J. ;

Suriawinata, Arief A. ;

Carrere, Nicolas ;

Buscail, Louis ;

Cordelier, Pierre .

CLINICAL CHEMISTRY, 2010, 56 (04) :603-612

[7] MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity [J].

Giovannetti, Elisa ;

Funel, Niccola ;

Peters, Godefridus J. ;

Del Chiaro, Marco ;

Erozenci, Leyla A. ;

Vasile, Enrico ;

Leon, Leticia G. ;

Pollina, Luca E. ;

Groen, Annemieke ;

Falcone, Alfredo ;

Danesi, Romano ;

Campani, Daniela ;

Verheul, Henk M. ;

Boggi, Ugo .

CANCER RESEARCH, 2010, 70 (11) :4528-4538

[8] Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival [J].

Greither, Thomas ;

Grochola, Lukasz F. ;

Udelnow, Andrej ;

Lautenschlaeger, Christine ;

Wuerl, Peter ;

Taubert, Helge .

INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (01) :73-80

[9] MicroRNA miR-155 is a biomarker of early pancreatic neoplasia [J].

Habbe, Nils ;

Koorstra, Jan-Bart M. ;

Mendell, Joshua T. ;

Offerhaus, G. Johan ;

Ryu, Ji Kon ;

Feldmann, Georg ;

Mullendore, Michael E. ;

Goggins, Michael G. ;

Hong, Seung-Mo ;

Maitra, Anirban .

CANCER BIOLOGY & THERAPY, 2009, 8 (04) :340-346

[10] The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis [J].

Hanoun, Naima ;

Delpu, Yannick ;

Suriawinata, Arief A. ;

Bournet, Barbara ;

Bureau, Christophe ;

Selves, Janick ;

Tsongalis, Gregory J. ;

Dufresne, Marlene ;

Buscail, Louis ;

Cordelier, Pierre ;

Torrisani, Jerome .

CLINICAL CHEMISTRY, 2010, 56 (07) :1107-1118

← 1 2 3 4 5 →